货号 | BAF620 |
别名 | HHV5wtgp117; vCXC1; vCXCL1; Y18 | 全称 | Cytomegalovirus UL146 |
应用 | Western Blot(0.1 µg/mL) |
目标/特异性 | Detects viral CMV UL146/vCXC1 in direct ELISAs and Western blots. |
使用方法 | Western Blot: 0.1 µg/mL |
来源 | Reconstitute at 0.2 mg/mL in sterile PBS. |
产品组分 |
供应商 | R&D Systems |
纯化方式 | Antigen Affinity-purified |
免疫原 | E. coli-derived recombinant viral CMV UL146/vCXC1 |
生物活性 | Viral |
标记 | Biotin |
溶解方法 | Reconstitute at 0.2 mg/mL in sterile PBS. |
背景 | Cytomegalovirus (CMV), a member of the beta herpesvirus subfamily, typically causes subclinical or latent infections in the normal adult population. However, CMV can cause congenital disease during pregnancy and is a human opportunistic pathogen that affects immunocompromised individuals. The CMV genome has been shown to contain homologs of cellular immunomodulatory proteins, including US28 (a CC chemokine receptor) and a MHC class I homolog. Virulent CMV clinical isolates have also been shown to carry at least 19 genes, designated UL133-UL151, that are not found in laboratory strains that have lost virulence characteristics. Two of these genes, UL146 and UL147, exhibit sequence similarity to CXC chemokines. The CMV UL146 open-reading frame encodes a 117 amino acid residue precursor protein with a predicted 22 residues signal peptide that is cleaved to generate the mature protein. Recombinant UL146 has been shown to induce calcium mobilization, chemotaxis and degranulation of neutrophils. |
运输条件 | Blue Ice |
存放说明 | -20℃ |
参考文献 |
|